Characterization of the novel HLA-C*17:01:18 allele by sequencing-based typing.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
12 2022
Historique:
received: 29 07 2022
accepted: 02 08 2022
pubmed: 4 8 2022
medline: 19 11 2022
entrez: 3 8 2022
Statut: ppublish

Résumé

HLA-C*17:01:18 differs from HLA-C*17:01:01:05 by one nucleotide substitution in codon 18 in exon 2.

Identifiants

pubmed: 35920676
doi: 10.1111/tan.14755
pmc: PMC9804487
doi:

Substances chimiques

HLA-C Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

646-648

Informations de copyright

© 2022 The Authors. HLA: Immune Response Genetics published by John Wiley & Sons Ltd.

Références

Nucleic Acids Res. 2020 Jan 8;48(D1):D948-D955
pubmed: 31667505
HLA. 2020 Jan;95(1):30-39
pubmed: 31577866
HLA. 2020 Sep;96(3):323-328
pubmed: 32602630
Tissue Antigens. 2010 Apr;75(4):291-455
pubmed: 20356336
HLA. 2022 Dec;100(6):646-648
pubmed: 35920676

Auteurs

Marine Cargou (M)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.

Vincent Elsermans (V)

CHU de Lille, Institut d'Immunologie-HLA, Bd du Professeur Jules Leclercq, Lille, France.

Isabelle Top (I)

CHU de Lille, Institut d'Immunologie-HLA, Bd du Professeur Jules Leclercq, Lille, France.

Elodie Wojciechowski (E)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
Univ. Bordeaux, CNRS, ImmunoConcEpT, Bordeaux, France.

Jonathan Visentin (J)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
Univ. Bordeaux, CNRS, ImmunoConcEpT, Bordeaux, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH